Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia

Despite treatment advances for sepsis and pneumonia, significant improvements in outcome have not been realized. Antiplatelet therapy may improve outcome in pneumonia and sepsis. In this study, the authors show that ticagrelor reduced leukocytes with attached platelets as well as the inflammatory bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sexton, Travis R., Zhang, Guoying, Macaulay, Tracy E., Callahan, Leigh A., Charnigo, Richard, Vsevolozhskaya, Olga A., Li, Zhenyu, Smyth, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
CLINICAL RESEARCH
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115703/
https://www.ncbi.nlm.nih.gov/pubmed/30175268
http://dx.doi.org/10.1016/j.jacbts.2018.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115703/
https://www.ncbi.nlm.nih.gov/pubmed/30175268
http://dx.doi.org/10.1016/j.jacbts.2018.05.005

Ejemplares similares